Adia Nutrition Inc

Adia Nutrition Inc has a basic capital structure with 94.4 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not yet quantifiable due to the lack of financial metrics in the valuation snapshot. The industry_config for the Food Processing sector emphasizes metrics such as EBITDA margins, ROIC, and working capital efficiency, which are not available for Adia Nutrition Inc at this time. Adia Nutrition Inc's revenue is concentrated in two primary segments: the supplement division and the medical division. The supplement division provides organic supplements, while the medical division operates clinics offering stem cell therapies. The company is also conducting a nationwide rollout of satellite locations for UCB-SC and exosome treatments. No geographic revenue breakdown is available, but the nationwide rollout suggests a broad geographic footprint. The company's growth trajectory is speculative, as no revenue history or outlook numeric deltas are available. The rollout of satellite locations and the introduction of new treatments like AdiaVita suggest a forward-looking strategy, but the absence of financial data makes it difficult to assess the pace or sustainability of growth. The risk assessment indicates low dilution potential, but liquidity risk remains unassessed. The lack of balance-sheet inputs and no going-concern language in source documents raises concerns about the company's financial transparency and stability. No specific dilution sources are identified in the available data. Recent events include the nationwide rollout of satellite locations for UCB-SC and exosome treatments, as well as the company's 18% equity position in Cement Factory, LLC. No recent filings or transcripts are available to provide further insight into the company's operations or strategic direction.